Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phosphoric acid + aluminium oxide is a prototype micro-abrasive dental paste developed by researchers at Misr University for Science and Technology. It is specifically designed for dental microabrasion to treat intrinsic enamel stains, such as those caused by mild to moderate dental fluorosis. The formulation consists of a 37% concentration of phosphoric acid combined with 50 µm alpha aluminum oxide (α-Al₂O₃) particles. The mechanism of action involves a dual approach: the phosphoric acid chemically dissolves the superficial layer of the stained enamel, while the aluminum oxide particles provide mechanical abrasion to remove the discolored tissue when applied with a rotating rubber cup. It has been studied in clinical trials as an alternative to commercial microabrasion agents like Antivet and Opalustre.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on phosphoric acid + aluminium oxide.